510 related articles for article (PubMed ID: 30061533)
1. mTOR and Tumor Cachexia.
Duval AP; Jeanneret C; Santoro T; Dormond O
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061533
[TBL] [Abstract][Full Text] [Related]
2. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
[TBL] [Abstract][Full Text] [Related]
3. Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse.
Manne ND; Lima M; Enos RT; Wehner P; Carson JA; Blough E
Int J Oncol; 2013 Jun; 42(6):2134-40. PubMed ID: 23589074
[TBL] [Abstract][Full Text] [Related]
4. A leucine-rich diet modulates the mTOR cell signalling pathway in the gastrocnemius muscle under different Walker-256 tumour growth conditions.
Cruz B; Oliveira A; Ventrucci G; Gomes-Marcondes MCC
BMC Cancer; 2019 Apr; 19(1):349. PubMed ID: 30975087
[TBL] [Abstract][Full Text] [Related]
5. Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.
Hardee JP; Montalvo RN; Carson JA
Oxid Med Cell Longev; 2017; 2017():8018197. PubMed ID: 29375734
[TBL] [Abstract][Full Text] [Related]
6. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation.
Tsoli M; Schweiger M; Vanniasinghe AS; Painter A; Zechner R; Clarke S; Robertson G
PLoS One; 2014; 9(3):e92966. PubMed ID: 24667661
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
[TBL] [Abstract][Full Text] [Related]
8. The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.
White JP; Baynes JW; Welle SL; Kostek MC; Matesic LE; Sato S; Carson JA
PLoS One; 2011; 6(9):e24650. PubMed ID: 21949739
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue dysfunction in cancer cachexia.
Daas SI; Rizeq BR; Nasrallah GK
J Cell Physiol; 2018 Jan; 234(1):13-22. PubMed ID: 30078199
[TBL] [Abstract][Full Text] [Related]
10. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
Talbert EE; Guttridge DC
Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
[TBL] [Abstract][Full Text] [Related]
11. High-Frequency Stimulation on Skeletal Muscle Maintenance in Female Cachectic Mice.
Sato S; Gao S; Puppa MJ; Kostek MC; Wilson LB; Carson JA
Med Sci Sports Exerc; 2019 Sep; 51(9):1828-1837. PubMed ID: 30933004
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
13. β-Hydroxy-β-methylbutyrate as a countermeasure for cancer cachexia: a cellular and molecular rationale.
Kim JS; Khamoui AV; Jo E; Park BS; Lee WJ
Anticancer Agents Med Chem; 2013 Oct; 13(8):1188-96. PubMed ID: 23919746
[TBL] [Abstract][Full Text] [Related]
14. Protein breakdown in cancer cachexia.
Sandri M
Semin Cell Dev Biol; 2016 Jun; 54():11-9. PubMed ID: 26564688
[TBL] [Abstract][Full Text] [Related]
15. Regulation of adipose tissue metabolism in cancer cachexia.
Bing C; Trayhurn P
Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):201-7. PubMed ID: 18403913
[TBL] [Abstract][Full Text] [Related]
16. An integrative transcriptome study reveals Ddit4/Redd1 as a key regulator of cancer cachexia in rodent models.
Niu M; Li L; Su Z; Wei L; Pu W; Zhao C; Ding Y; Wazir J; Cao W; Song S; Gao Q; Wang H
Cell Death Dis; 2021 Jun; 12(7):652. PubMed ID: 34175899
[TBL] [Abstract][Full Text] [Related]
17. Consequences of Late-Stage Non-Small-Cell Lung Cancer Cachexia on Muscle Metabolic Processes.
Murton AJ; Maddocks M; Stephens FB; Marimuthu K; England R; Wilcock A
Clin Lung Cancer; 2017 Jan; 18(1):e1-e11. PubMed ID: 27461772
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue rearrangement in cancer cachexia: The involvement of β3-adrenergic receptor associated pathways.
Mota INR; Satari S; Marques IS; Santos JMO; Medeiros R
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189103. PubMed ID: 38679401
[TBL] [Abstract][Full Text] [Related]
19. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
Arneson PC; Doles JD
Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
[TBL] [Abstract][Full Text] [Related]
20. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
